Company Filing History:
Years Active: 2000-2012
Title: The Innovative Contributions of Urs Eggmann
Introduction
Urs Eggmann is a notable inventor based in Flurlingen, Switzerland. He has made significant contributions to the field of pulmonary surfactants, particularly through his innovative approaches to peptide synthesis. With a total of 3 patents to his name, Eggmann's work has implications for large-scale production processes in the pharmaceutical industry.
Latest Patents
Eggmann's latest patents focus on the liquid phase peptide synthesis of KL-4 pulmonary surfactant. The first patent describes improved liquid phase processes for the preparation of the 21-residue protein component, (Lys-Leu)-Lys, of the pulmonary surfactant KL-4. This invention emphasizes methods that are amenable to large-scale synthesis, including a process that employs saponification of an ester to reduce inherent racemization of the α-carbon. The second patent reiterates these advancements, highlighting the efficiency and scalability of the processes developed.
Career Highlights
Urs Eggmann is currently associated with Ortho Pharmaceutical Corporation, where he continues to innovate in the field of peptide synthesis. His work has not only advanced scientific understanding but also contributed to practical applications in medicine.
Collaborations
Eggmann has collaborated with esteemed colleagues such as Ahmed F Abdel-Magid and Cynthia Anne Maryanoff. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Urs Eggmann's contributions to the field of pulmonary surfactants through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence large-scale synthesis processes, making a significant impact in the pharmaceutical industry.